Withaferin-A is a novel HSF-1 inhibitor with potent antitumor effects in melanoma in vivo

被引：1
|
作者：
Samadi, Abbas K.
Mukerji, Ridhwi
Shah, Anuj
Bron, Tyler
Timmermann, Barbara N.
Cohen, Mark S.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B84
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B84
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ecubectedin is a novel transcriptional inhibitor that displays potent antitumor effects in vitro and in vivo
    Nunez, Gema Santamaria
    Diez, Marta Martinez
    Guillen, Maria Jose
    Garrido-Martin, Eva Maria
    Aviles, Pablo
    Cuevas, Carmen
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [2] On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores
    Ali, Sharique A.
    Meitei, Keisham V.
    [J]. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2011, 31 (05) : 359 - 366
  • [3] Antitumor and radiosensitizing effects of withaferin a on mouse Ehrlich ascites carcinoma in vivo
    Sharada, AC
    Solomon, FE
    Devi, PU
    Udupa, N
    Srinivasan, KK
    [J]. ACTA ONCOLOGICA, 1996, 35 (01) : 95 - 100
  • [4] Antitumor effects of bosentan, a novel endothelin receptor inhibitor, on melanoma cells
    Sekulic, A
    Pittelkow, MR
    Markovic, S
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 213 - 213
  • [5] IN-VIVO GROWTH-INHIBITORY AND RADIOSENSITIZING EFFECTS OF WITHAFERIN-A ON MOUSE EHRLICH ASCITES-CARCINOMA
    DEVI, PU
    SHARADA, AC
    SOLOMON, FE
    [J]. CANCER LETTERS, 1995, 95 (1-2) : 189 - 193
  • [6] SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models
    Chen, Xin
    Ji, Pan
    Yang, Hui-Wen
    Yang, Ling-Ling
    Zhou, Shu
    Zhong, Lei
    Ma, Shuang
    Fu, Xiao-Yu
    Zhou, Chan
    Li, Guo-Bo
    Zheng, Ming-Wu
    Wei, Yu-Quan
    Yang, Sheng-Yong
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (01) : 138 - 153
  • [7] BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity
    Siemeister, Gerhard
    Mengel, Anne
    Bone, Wilhelm
    Schroder, Jens
    Zitzmann-Kolbe, Sabine
    Briem, Hans
    Fernandez-Montalvan, Amaury E.
    Holton, Simon
    Monning, Ursula
    von Ahsen, Oliver
    Johanssen, Sandra
    Cleve, Arwed
    Hitchcock, Marion
    Meyer, Kirstin
    von Nussbaum, Franz
    Brands, Michael
    Mumberg, Dominik
    Ziegelbauer, Karl
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity
    Ott, Gregory R.
    Tripathy, Rabindranath
    Cheng, Mangeng
    McHugh, Robert
    Anzalone, Andrew V.
    Underiner, Ted L.
    Curry, Matthew A.
    Quail, Matthew R.
    Lu, Lihui
    Wan, Weihua
    Angeles, Thelma S.
    Albom, Mark S.
    Aimone, Lisa D.
    Ator, Mark A.
    Ruggeri, Bruce A.
    Dorsey, Bruce D.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 493 - 498
  • [9] Novel Microtubule Polymerization Inhibitor with Potent Antiproliferative and Antitumor Activity
    Arora, Sonia
    Wang, Xin I.
    Keenan, Susan M.
    Andaya, Christina
    Zhang, Qiang
    Peng, Youyi
    Welsh, William J.
    [J]. CANCER RESEARCH, 2009, 69 (05) : 1910 - 1915
  • [10] Development and characterization of ADC999: A novel, potent orally available Wee1 inhibitor with robust antitumor efficacy in vivo
    Gavory, Gerald
    O'Dowd, Colin
    Rozycka, Ewelina
    Boyd, Caroline
    Gorges, Beronia
    McLean, Estelle
    Daubriac, Julien
    Rountree, Shane
    Shepherd, Steven
    Burton, Stephanie
    McFarland, Mary
    Treder, Adam
    Wilkinson, Andy
    Burkamp, Frank
    Harrison, Tim
    [J]. CANCER RESEARCH, 2017, 77
12345